Neurontin 1: Interim Status Report
Introduction. Neurontin, is Pfizer’s (formerly Warner-Lambert’s) $ 2 billion a year FDA-approved epilepsy medication. Warner Lambert’s first generation patents have [...]
Neurontin 2: Generic Competition likely in September ‘02
The battle over Neurontin (whose active ingredient is gabapentin) is heating up: A hearing is scheduled for Monday, September 9, [...]
Related Case Type
